Status:
COMPLETED
Prediction of Sepsis After Percutaneous Nephrolithotomy
Lead Sponsor:
Tongji Hospital
Conditions:
Percutaneous Nephrolithotomy
Infection
Eligibility:
All Genders
18+ years
Brief Summary
We aim to determine the preoperative predictors of sepsis after percutaneous nephrolithotomy (PCNL) in patients with unilateral, solitary and proximal ureteral stones.
Eligibility Criteria
Inclusion
- (1) PCNL was performed to treat unilateral, solitary, and proximal ureteral stones; and (2) age ≥18 years
Exclusion
- anatomical renal abnormalities (horseshoe kidney, solitary kidney, transplant kidney and kidney duplication)
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2020
Estimated Enrollment :
745 Patients enrolled
Trial Details
Trial ID
NCT04340037
Start Date
March 1 2019
End Date
February 20 2020
Last Update
April 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030